Practical clinical utility of dna ploidy for managing patients with prostate carcinoma
- 30 April 1995
- Vol. 45 (4) , 558-562
- https://doi.org/10.1016/s0090-4295(99)80042-9
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Consensus review of the clinical utility of dna content cytometry in prostate cancerCytometry, 1993
- Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumorsCancer, 1992
- Hormonal Treatment at Time of Radical Retropubic Prostatectomy for Stage D1 Prostate Cancer: Results of Long-Term FollowupJournal of Urology, 1992
- The Prognostic Value of Deoxyribonucleic Acid Flow Cytometric Analysis in Stage D2 Prostatic CarcinomaJournal of Urology, 1991
- Dna Flow Cytometry in Carcinoma of the Prostate for Diagnosis, Prognosis and Study of Tumor BiologyActa Oncologica, 1991
- The Prognostic Value of Modal Deoxyribonucleic Acid in Low Grade, Low Stage Untreated Prostate CancerJournal of Urology, 1990
- Stage B Prostate AdenocarcinomaArchives of Surgery, 1990
- Flow Cytometric Determination of Ploidy in Prostatic Adenocarcinoma: A Comparison with Seminal Vesicle Involvement and Histopáthglogicál Grading as a Predictor of Clinical RecurrenceJournal of Urology, 1988
- Correlation between Ploidy and Prognosis in Prostatic CarcinomaJournal of Urology, 1973
- Tumour ploidy and prognosis in carcinomas of the bladder and prostate.British Journal of Cancer, 1966